Arteriovenous Fistula Toxicity
Arteriovenous Fistula Toxicity
复制标题
DOI：
10.1159/000322695
复制
发表时间：
2011-01-01
影响因子：
3
通讯作者：
Winchester, James F.
中科院分区：
文献类型：
--
作者：
Amerling, Richard;Ronco, Claudio;Winchester, James F.
动静脉内瘘（AVF）自20世纪60年代问世以来一直是血液透析治疗的支柱和首选入路，因为其寿命长且抗感染。然而，AVF不是良性的。有明显的原发性衰竭，以及心脏、血管和其他不太清楚的并发症。它们一起代表毒性，可引起相当大的发病率和死亡率。基于AVF毒性被忽视的指南的官方政策推动了这些器械使用的增加，并可能产生不良后果。版权所有（C）2011 S. Karger AG，巴塞尔
The arteriovenous fistula (AVF) has been a mainstay of hemodialysis treatments and the preferred access route since its inception in the 1960s, due to its longevity and resistance to infection. However, the AVF is not benign. There is significant primary failure, as well as cardiac, vascular, and other, less well recognized, complications. Together, they represent toxicity, to which considerable morbidity and mortality can be attached. Official policy, based on guidelines where AVF toxicity is given short shrift, drives an increase in use of these devices, and may have undesired consequences. Copyright (C) 2011 S. Karger AG, Basel